Status:
ACTIVE_NOT_RECRUITING
The Bacterial Composition of the Stomach in Reflux Disease
Lead Sponsor:
Imperial College London
Conditions:
GORD
Oesophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Gastric and oesophageal (OG) cancer associated with poor long term outcome as overall less than 25% of patients survive for more than 5 years due to late recognition of the disease. Growing evidence s...
Eligibility Criteria
Inclusion
- Patients who deemed necessary for an upper gastro intestinal endoscopy for clinical reasons and consent for additional gastric mucosal biopsies for study purposes
Exclusion
- Patients who have upper GI malignancy
Key Trial Info
Start Date :
June 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03835663
Start Date
June 4 2018
End Date
December 31 2024
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare, St Mary's Hospital, Paddington
London, United Kingdom, W2 1NY